News

A new study links urinary metabolites from organophosphorus pesticides to increased age-related macular degeneration risk.
AAV204 is a novel adeno-associated virus (AAV) capsid from the AIM capsid library licensed by Abeona from the University of ...
RGN-259 is a thymosin beta-4–based eye drop designed to rival Dompé’s Oxervate, the only FDA-approved prescription eye drop ...
Lupin Limited secures FDA approval for Loteprednol Etabonate Ophthalmic Gel, enhancing treatment options for postoperative ...
New technologies and a proactive mindset are transforming how glaucoma is diagnosed and treated—and redefining what ...
A new study demonstrates that handheld nanopore sequencers can rapidly identify eye infection pathogens using only a ...
Nanoscope Therapeutics formed the Vision Advisory Committee to guide its efforts in retinal care, focusing on retinitis ...
In addition to Prevent Blindness’s usual free resources, the organization is providing a dedicated webpage, fact sheets, and ...
The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...
Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...
Yesafili is a VEGF inhibitor indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD), ...
ST-100 shows promise as a fast-acting treatment for dry eye disease, offering rapid relief and unique collagen repair ...